FY26 Budget Standoff: What’s At Stake for Patients, Researchers

 

If a deal on fiscal year 2026 appropriations is not reached by Tuesday (September 30) at midnight, the government will shut down.

sticking point of negotiations is the Affordable Care Act's (ACA) enhanced premium tax credits, which are due to expire at the end of the year. Without these subsidies, analysts warn that "out-of-pocket premium payments for ACA Marketplace enrollees are projected to increase by over 75 percent on average."

Earlier this month, the House passed a Continuing Resolution (CR) along mostly party lines that would keep the government funded at current levels through November 21st. That CR has been rejected by Senate Democrats, primarily for failing to address the healthcare subsidies.

Our friends at Research!America offer a helpful primer (see graphic below) on CRs and government shutdowns, including potential implications for patient care, research projects, and grant funding. Among the many healthcare impacts is the inability of the NIH Clinical Center to admit new patients unless it is medically necessary (current patients will continue to receive care) or to initiate new clinical trials.

If and when a CR is passed, it will give House and Senate appropriators more time to negotiate FY26 funding.

See also: Appropriations Watch: The Latest on Cancer Funding

As cancer advocates, we will continue working with partner organizations and healthcare coalitions. Together, we call on Congress to stand by its proven legacy of bipartisan support for cancer research through strong funding of the National Institutes of Health (NIH) and its National Cancer Institute (NCI).

Join us by sending a message to Congress using our action center.